The news is not getting better for former UFC Heavyweight Champion Brock Lesnar. Last week, when word got out that he failed an out-of-competition drug test, Lesnar told the Associated Press, “We will get to the bottom of this.”
The UFC announced on Tuesday that Lesnar also failed an in-competition drug test from a July 9 sample taken by USADA. That would be the test he took on the night of his fight with Mark Hunt. We noted on Friday that Lesnar failed an out-competition drug test from a sample collected on June 28.
Lesnar failed both tests for the same banned substance, the UFC press release stated. USADA has yet to reveal the name of the drug that Lesnar test positive for and won’t unless Lesnar makes it public first himself. That will likely come out during Lesnar’s hearing.
Lesnar passed several drug tests before failing the one from June 28. Lesnar is facing a two-year ban from the UFC.
Here is the full statement from UFC:
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.
“Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”
